Postmenopausal women may benefit from estrogen compound research
Postmenopausal women have increased risk of non-alcoholic fatty liver disease due to loss of estrogen from metabolic changes. A high-fat […]
» Read moreHome »
(HealthDay)—Having a partner and good physical health are key factors for continuation of sexual activity among postmenopausal women, according to […] (HealthDay)—Evenity (romosozumab-aqqg) was approved for the treatment of osteoporosis in postmenopausal women with a high risk for fracture, the U.S. […]
Having a partner, health impact postmenopausal sexual activity
FDA approves osteoporosis therapy for high-risk postmenopausal women
